Rheumaderm pp 181-186 | Cite as


Diagnosis and Evaluation of Dermatomyositis, Polymyositis, and Inclusion-Body Myositis
  • I. Krajnc
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 455)


In diseases of an unknown etiology, such as the idiopathic inflammatory myopathies, we must tackle first of all the question of classification and the degree of disease activity before we can institute treatment. The majority of idiopathic inflammatory myopathies are diagnosed clinically and confirmed by biopsy. The presently applicable methods of diagnosis and evaluation of idiopathic inflammatory myopathy have certain limitations, and hence it is necessary to apply new methods of rating the disease activities. Magnetic resonance imaging (MRI) and 99m-technetium muscle-scanning are the latest noninvasive methods for evaluation of disease activities with myositis. Future laboratory methods to determine the numerous myositis-specific autoantibodies will probably enable identification of subsets of these diseases.


Interstitial Lung Disease Idiopathic Inflammatory Myopathy Facial Erythema Amyopathic Dermatomyositis Anti Synthetase Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dalakas, MC.: Current Treatment of the Inflammatory Myopathies. Curr Op Rheumatol 6: 595–601 (1994).CrossRefGoogle Scholar
  2. 2.
    Genth E., Mierau R.: Jo-1-Antisynthetase-syndrom Verbessern Autoantikorper Die Klassification von Myositiden? Z Rheumatol 52: 259–263 (1993).PubMedGoogle Scholar
  3. 3.
    Kagen L.J.: Myositis and Myopathies: Curr Op Rheumatol. 6: 549–551 (1994).CrossRefGoogle Scholar
  4. 4.
    Krajnc I., Gorišek B.: Polymyositis, Dermatomyositis und Einschluαolymyositis-Jkubuscge Übersicht der Aktuellen Kriterien in der Diagnostik und Therapie Akt. Rheumatol 22: 123–130 (1997).Google Scholar
  5. 5.
    Kalovidovris A.D.: The Role of Cell-Mediated Immunity in Polymyositis. Curr. Op.. Rheumatol 3: 911–918 (1991).CrossRefGoogle Scholar
  6. 6.
    Mantegazza R., Bernasconi B.: Cellular Aspects of Myositis. Curr Op Rheumatol. 6: 568–574 (1994)..CrossRefGoogle Scholar
  7. 7.
    Taylor A.J., Wortham D.C., Burger J.R., Rogan K.M.: The Heart in Polymyositis: A Prospective Evaluation of 26 Patients. Cln. Cardiol 16: 802–808 (1993).CrossRefGoogle Scholar
  8. 8.
    Treher E., Niederhoff A., Gellissen U., Schmidt P., Dornberg M., Peter H.H.: Polymyositis und Jo-1 Syndrom. Z Rheumatol 52: 301–306 (1993).PubMedGoogle Scholar
  9. 9.
    Yale S.H., Adlakha A., Stanton M.S.: Dermatomyositis with Pericardial Tamponade and Polymyositis with Pericardial Effusion. Amer Heart J. 129: 997–999 (1993).CrossRefGoogle Scholar
  10. 10.
    Wortmann R.L.: Inflammatory Disease of Muscle in Kelley W.N. Harris E.D., Ruddy S., Sledge C.B.; Textbook of Rheumatology, 4th Edit., W.B.Ssunders Co., Philadelphia. 1159–1188 (19Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • I. Krajnc
    • 1
  1. 1.Department Of Internal MedicineRheumatology Teaching Hospital MariborSlovenia

Personalised recommendations